"
One-month immunotherapy trial in treatment-failed TB patients"
written by Olga V. Arjanova, Dmitry A. Butov, Natalia D. Prihoda, Svetlana I. Zaitzeva, Larisa V. Yurchenko, Nina I. Sokolenko, Anna L. Stepanenko, Tatyana S. Butova, Elena A. Grinishina, Olga A. Maksimenko, Vichai Jirathitikal, Aldar S. Bourinbaiar, Valery M. Frolov, Galyna A. Kutsyna,
published by
Open Journal of Immunology,
Vol.1 No.2, 2011
has been cited by the following article(s):
[1]
|
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis
|
|
Immunotherapy,
2017 |
|
|
[2]
|
Double-blind, placebo-controlled, 1: 1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with …
|
|
2017 |
|
|
[3]
|
Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with …
|
|
International Journal of Mycobacteriology,
2016 |
|
|
[4]
|
Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7
|
|
Human vaccines & immunotherapeutics,
2013 |
|
|
[5]
|
Therapeutic Vaccination of Treatment-Failed TB Patients on
|
|
Journal of Mycobacterial Diseases,
2012 |
|
|
[6]
|
Immune approaches in tuberculosis therapy: a brief overview
|
|
Expert review of anti-infective therapy,
2012 |
|
|
[7]
|
Therapeutic Vaccination of Treatment-Failed TB Patients on Palliative” Support Consisting of Isoniazid and Rifampicin
|
|
Mycobact Diseases S,
2012 |
|
|
[8]
|
Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV
|
|
2012 |
|
|
[1]
|
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis
Immunotherapy,
2017
DOI:10.2217/imt-2016-0079
|
|
|
[2]
|
Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy
International Journal of Mycobacteriology,
2016
DOI:10.1016/j.ijmyco.2016.06.012
|
|
|
[3]
|
Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7)
Immunotherapy,
2013
DOI:10.2217/imt.13.110
|
|
|
[4]
|
Randomized, placebo-controlled phase II trial of heat-killedMycobacterium vaccae(Longcom batch) formulated as an oral pill (V7)
Human Vaccines & Immunotherapeutics,
2013
DOI:10.4161/hv.25280
|
|
|
[5]
|
Immune approaches in tuberculosis therapy: a brief overview
Expert Review of Anti-infective Therapy,
2012
DOI:10.1586/eri.12.1
|
|
|
[6]
|
Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV
Immunotherapy,
2012
DOI:10.2217/imt.12.59
|
|
|